Sakatoku, Kazuki
Kim, Sung-Won http://orcid.org/0000-0003-4938-3340
Okamura, Hiroshi
Kanaya, Minoru
Kato, Koji
Yamasaki, Satoshi
Uchida, Naoyuki
Kobayashi, Hikaru
Fukuda, Takahiro
Takayama, Nobuyuki
Ishikawa, Jun
Nakazawa, Hideyuki
Sakurai, Masatoshi
Ikeda, Takashi
Kondo, Tadakazu
Yoshioka, Satoshi
Miyamoto, Toshihiro
Kimura, Takafumi
Ichinohe, Tatsuo
Atsuta, Yoshiko
Kondo, Eisei
Funding for this research was provided by:
National Cancer Research and Development Fund (2020-A-15)
Article History
Received: 22 December 2021
Accepted: 23 September 2022
First Online: 5 October 2022
Declarations
:
: This study was approved by the data management committee of the Japanese Society for Transplantation and Cellular Therapy and by the institutional review board of Osaka City University (Osaka, Japan). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: The Transplant Registry Unified Management Program (TRUMP) database of the Japanese Society for Transplantation and Cellular Therapy and the Japanese Data Center for Hematopoietic Cell Transplantation includes physician-reviewed data. Observational studies based on the TRUMP database are performed with informed consent.
: K.K. received honoraria from MSD K.K., Chugai Pharmaceutical Co., Ltd. N.T. received honoraria from Chugai Pharmaceutical Co., Ltd. and Pfizer Inc., Sanofi S.A., and research funding from Chugai Pharmaceutical Co., Ltd. The remaining authors declare no competing financial interests.